Toxicometabolomics-based cardiotoxicity evaluation of Thiazolidinedione exposure in human-derived cardiomyocytes

被引:4
|
作者
Al Sultan, Abdullah [1 ,2 ]
Rattray, Zahra [1 ]
Rattray, Nicholas J. W. [1 ,3 ]
机构
[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Scotland
[2] Kuwait Univ, Fac Pharm, Safat 13110, Kuwait
[3] Univ Strathclyde, Strathclyde Ctr Mol Biosci, Glasgow City G4 0RE, Scotland
关键词
Thiazolidinediones; Toxicometabolomics; LC-MS; Cardiotoxicity; Amino acids; Carnitines; HEART; INHIBITION;
D O I
10.1007/s11306-024-02097-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThiazolidinediones (TZDs), represented by pioglitazone and rosiglitazone, are a class of cost-effective oral antidiabetic agents posing a marginal hypoglycaemia risk. Nevertheless, observations of heart failure have hindered the clinical use of both therapies.ObjectiveSince the mechanism of TZD-induced heart failure remains largely uncharacterised, this study aimed to explore the as-yet-unidentified mechanisms underpinning TZD cardiotoxicity using a toxicometabolomics approach.MethodsThe present investigation included an untargeted liquid chromatography-mass spectrometry-based toxicometabolomics pipeline, followed by multivariate statistics and pathway analyses to elucidate the mechanism(s)of TZD-induced cardiotoxicity using AC16 human cardiomyocytes as a model, and to identify the prognostic features associated with such effects.ResultsAcute administration of either TZD agent resulted in a significant modulation in carnitine content, reflecting potential disruption of the mitochondrial carnitine shuttle. Furthermore, perturbations were noted in purine metabolism and amino acid fingerprints, strongly conveying aberrations in cardiac energetics associated with TZD usage. Analysis of our findings also highlighted alterations in polyamine (spermine and spermidine) and amino acid (L-tyrosine and valine) metabolism, known modulators of cardiac hypertrophy, suggesting a potential link to TZD cardiotoxicity that necessitates further research. In addition, this comprehensive study identified two groupings - (i) valine and creatine, and (ii) L-tryptophan and L-methionine - that were significantly enriched in the above-mentioned mechanisms, emerging as potential fingerprint biomarkers for pioglitazone and rosiglitazone cardiotoxicity, respectively.ConclusionThese findings demonstrate the utility of toxicometabolomics in elaborating on mechanisms of drug toxicity and identifying potential biomarkers, thus encouraging its application in the toxicological sciences. (245 words)
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Determination of cardiotoxicity by verapamil and valproic acid on human embryonic stem cells derived cardiomyocytes
    Jagtap, Smita
    Meganathan, Kesavan
    Wagh, Vilas
    Winkler, Johannes
    Hescheler, Juergen
    Sachinidis, Agapios
    HUMAN GENE THERAPY, 2009, 20 (11) : 1453 - 1453
  • [22] Physics-based and Human-derived Information Fusion for Analysts
    Blasch, Erik
    Nagy, James
    Scott, Steve
    Okoth, Joshua
    Hinman, Mike
    NEXT-GENERATION ANALYST V, 2017, 10207
  • [23] Mirroring Action Potentials: Label-Free, Accurate, and Noninvasive Electrophysiological Recordings of Human-Derived Cardiomyocytes
    Barbaglia, Andrea
    Dipalo, Michele
    Melle, Giovanni
    Iachetta, Giuseppina
    Deleye, Lieselot
    Hubarevich, Aliaksandr
    Toma, Andrea
    Tantussi, Francesco
    De Angelis, Francesco
    ADVANCED MATERIALS, 2021, 33 (07)
  • [24] Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals
    Shi, Miaoying
    Tien, Nguyen T.
    de Haan, Laura
    Louisse, Jochem
    Rietjens, Ivonne M. C. M.
    Bouwmeester, Hans
    TOXICOLOGY IN VITRO, 2020, 67
  • [25] microRNAs as signatures of structural cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Gryshkova, V.
    Palmer, J.
    Smith, A.
    Burrier, R.
    Colwell, M.
    Delaunois, A.
    da Costa, A. Nogueira
    Valentin, J. -P.
    TOXICOLOGY LETTERS, 2018, 295 : S58 - S58
  • [26] Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
    Maillet, Agnes
    Tan, Kim
    Chai, Xiaoran
    Sadananda, Singh N.
    Mehta, Ashish
    Ooi, Jolene
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    Ghosh, Sujoy
    Shim, Winston
    Brunham, Liam R.
    SCIENTIFIC REPORTS, 2016, 6
  • [27] Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations
    Cohen, J. D.
    Babiarz, J. E.
    Abrams, R. M.
    Guo, L.
    Kameoka, S.
    Chiao, E.
    Taunton, J.
    Kolaja, K. L.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 257 (01) : 74 - 83
  • [28] A new suite of media for cardiotoxicity and drug discovery studies with human iPSC-derived cardiomyocytes
    Filali, O.
    Armstrong, A.
    Livingston, M.
    Carlson, C.
    Rieger, C.
    Meyer, N.
    Vaidyanathan, R.
    Rajesh, D.
    TOXICOLOGY LETTERS, 2022, 368 : S75 - S75
  • [29] Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity
    Sharma, Arun
    McKeithan, Wesley L.
    Serrano, Ricardo
    Kitani, Tomoya
    Burridge, Paul W.
    del Alamo, Juan C.
    Mercola, Mark
    Wu, Joseph C.
    NATURE PROTOCOLS, 2018, 13 (12) : 3018 - 3041
  • [30] Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
    Agnes Maillet
    Kim Tan
    Xiaoran Chai
    Singh N. Sadananda
    Ashish Mehta
    Jolene Ooi
    Michael R. Hayden
    Mahmoud A. Pouladi
    Sujoy Ghosh
    Winston Shim
    Liam R. Brunham
    Scientific Reports, 6